References
- Valle J, Wasan H, Palmer DH et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N. Engl. J. Med.362, 1273–1281 (2010).
- Valle JW, Wasan H, Johnson P et al. Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised Phase II study – the UK ABC-01 Study. Br. J. Cancer101, 621–627 (2009).
- Fuks D, Bartoli E, Delcenserie R et al. Biliary drainage, photodynamic therapy and chemotherapy for unresectable cholangiocarcinoma with jaundice. J. Gastroenterol. Hepatol.24, 1745–1752 (2009).
- Bergman AM, Ruiz van Haperen VW, Veerman G et al. Synergistic interaction between cisplatin and gemcitabine in vitro. Clin. Cancer Res.2, 521–530 (1996).
- Peters GJ, Bergman AM, Ruiz van Haperen VW et al. Interaction between cisplatin and gemcitabine in vitro and in vivo. Semin. Oncol.22, 72–79 (1995).
- Thall PF. A review of Phase 2–3 clinical trial designs. Lifetime Data Anal.14, 37–53 (2008).
- Igarashi Y, Okano N, Ito K et al. Effectiveness of peroral cholangioscopy and narrow band imaging for endoscopically diagnosing the bile duct cancer. Dig. Endosc.21(Suppl. 1), S101–S102 (2009).
- Kawakami H, Kuwatani M, Etoh K et al. Endoscopic retrograde cholangiography versus peroral cholangioscopy to evaluate intraepithelial tumor spread in biliary cancer. Endoscopy41, 959–964 (2009).